Sana Biotechnology Inc (NAS:SANA)
$ 6.695 -0.225 (-3.25%) Market Cap: 1.48 Bil Enterprise Value: 1.33 Bil PE Ratio: 0 PB Ratio: 3.93 GF Score: 39/100

Sana Biotechnology Inc at Citi BioPharma Conference Transcript

Sep 06, 2023 / 02:30PM GMT
Release Date Price: $5.92 (+2.07%)
Samantha Lynn Semenkow
Citigroup Inc., Research Division - VP

All right, welcome. Thank you everyone. It's a pleasure here to host Steve Harr, CEO of Sana Biotechnology. Steve, thank you for being with us today.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

(inaudible).

Samantha Lynn Semenkow
Citigroup Inc., Research Division - VP

I want to if both mics working.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

Can you hear me now? There we go.

Questions & Answers

Samantha Lynn Semenkow
Citigroup Inc., Research Division - VP

All right. Great. Well, then maybe you can just start us off for those that are a little bit less familiar with Sana, and just giving maybe a 2-minute high-level overview of the company, what you do, where you're working towards.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot